Ashwini D. Sharan, MD FACS Professor of Neurosurgery

Dr. Ashwini Sharan is a professor in the departments of neurosurgery and neurology at Sidney Kimmel Medical College at Thomas Jefferson University. He has been in practice for 15 years and his practice focuses on surgery for epilepsy, neuromoduatory surgery, and spinal neurosurgery. At Thomas Jefferson University, Dr. Sharan provides unique expertise in deep brain stimulation for Parkinson’s disease and essential tremor. His expertise also includes intrathecal pump implantation for spasticity, spinal cord stimulation for chronic pain disorders, and vagal nerve stimulation for epilepsy. In addition, he leads the surgical epilepsy program at Thomas Jefferson University, where approximately 100 patients per year are treated with surgery and a majority are cured. In addition to his clinical work, Dr. Sharan is a true academician. He has been awarded the William H. Sweet Young Investigator Award, the William Buchhiet Teacher of the Year Award, was named by Philadelphia Magazine as a Rising Star at age 40, and was named one of America’s Top Doctors. He has completed fellowship training at the Cleveland Clinic Foundation in functional neurosurgery with Ali Rezai and fellowship in spinal neurosurgery with Ed Benzel. Dr. Sharan is a leading researcher in advance functional imaging of the brain for patients with epilepsy. In addition to these responsibilities, he is currently the program director of the Jefferson Neurosurgery residency. He is president for the North American Neuromodulation Society and president-elect for the Congress of Neurological Surgeons. He has authored more than one hundred publications and given countless invited talks. Dr. Sharan has been a faculty member for several review courses throughout the United States and internationally. Dr. Sharan is actively involved in innovation in the field of neuromodulation. He holds multiple patents in neurostimulation and neurosurgery. He was part of the founding team member in Intelect Medical and Endius. He is currently part of the active founding members for Cerebral Therapeutics and Mudjala. He holds board positions in Tiger Labs and Neurotarget.